ALX Oncology

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALX Oncology and other ETFs, options, and stocks.

About ALXO

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications.

CEO

Jason Lettmann

CEOJason Lettmann

Employees

Employees80

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2015

Founded2015

Employees

Employees80

ALXO Key Statistics

Market cap

25.95M

Market cap25.95M

Price-Earnings ratio

-0.20

Price-Earnings ratio-0.20

Dividend yield

—

Dividend yield—

Average volume

397.24K

Average volume397.24K

High today

$0.50

High today$0.50

Low today

$0.4627

Low today$0.4627

Open price

$0.4825

Open price$0.4825

Volume

369.11K

Volume369.11K

52 Week high

$11.08

52 Week high$11.08

52 Week low

$0.4051

52 Week low$0.4051

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own ALXO. This list is generated using Robinhood data, and it’s not a recommendation.